Standard or High Dose Chemoradiotherapy, with or Without the Protease Inhibitor Nelfinavir, for the Treatment of Locally Advanced Pancreatic Cancer: Efficacy, Safety and Health-Related Quality of Life Outcomes from the Multi-Centre Two Stage Phase 1/Randomised Phase 2 SCALOP-2 Study

Mukherjee S., Qi C., Shaw R., Jones C., Bridgewater J., Radhakrishna G., Patel N., Holmes J., Virdee PS., Tranter B., Parsons P., Falk S., Wasan H., Ajithkumar TV., Holyoake D., Roy R., Scott-Brown M., Hurt CN., Sebag-Montefiore D., Maughan T., Hawkins M., Corrie P.

DOI

10.2139/ssrn.4706360

Type

Preprint

Publication Date

2024-01-01T00:00:00+00:00

Permalink More information Close